How Mark Gorman of Maiden Biosciences Inc is Advancing Wound Care Using Collagen

Maiden Biosciences Inc has spent the last decade advancing collagen-based solutions designed to support wound management by complementing the body's natural recovery processes. Founded by Mark Gorman, the company focuses on providing collagen sheet and powder products that are FDA-registered, addressing wounds across a wide spectrum, including diabetic foot ulcers, pressure wounds, surgical incisions, burns, and traumatic injuries. The company combines scientific rigor with practical applications, developing solutions that support both patients and healthcare providers in managing wounds effectively.

"The science behind our product lies within our own biological processes," Gorman says. "Collagen is what your skin is made of. When introduced to a wound, the body can recognize it as a biological, organic material, allowing the wound to move out of the inflammatory phase into an environment that supports natural tissue management. Cells interact with the collagen, absorbing and using it to maintain an optimal balance between moisture and protection."

Maiden Biosciences' products are designed for moderate to heavy exudating wounds, ensuring that excess fluid is absorbed without compromising a moist environment, which is essential for effective wound care. It can create a balance between a wet and dry environment, aiming to make the wound area optimal for healing.

Additionally, the collagen dressing products are designed to help control minor bleeding, adding an extra layer of protection for surgical, traumatic, or post-procedure wounds. The bovine collagen used in both sheet and powder formulations could aid in improving patient comfort and decreasing the frequency of dressing changes required.

The company incorporates Type I collagen, which can bind to several excessive proteases and inflammatory cytokines within the exudates of chronic wounds, and in doing so, the products strive to preserve the collagen's molecular structure.

This capability helps stabilize the wound environment and provides a supportive scaffold for cellular activity, making it suitable for a wide range of applications, from chronic wounds like diabetic foot ulcers and leg ulcers to acute wounds such as burns, abrasions, lacerations, and surgical incisions.

The company's dual product line, sheets and powders, offers versatility for different clinical scenarios. Collagen sheets provide broad coverage, while collagen powders allow application in areas with movement or difficult-to-reach locations, giving clinicians flexibility to tailor treatment to individual patient needs.

Gorman notes that both collagen formulations can be easily applied, integrating seamlessly into existing treatment plans, and can be changed daily or left in place longer depending on the clinical situation. The dressings attempt to meet the criteria for conservative wound management, often serving as a first-line approach before more advanced interventions. Due to the products' ability to create a supportive environment for tissue recovery, Gorman highlights that they can be well-suited for regenerative medicine applications.

"Our approach is about supporting the body," Gorman emphasizes. "By maintaining the right environment for cells to recognize and utilize collagen, we're striving to manage wounds effectively for diabetic, surgical, aging, and obese patients. This allows physicians to provide care that works with the body's natural processes while optimizing comfort and recovery."

With a decade of innovation behind it, Maiden Biosciences Inc continues to explore new opportunities in regenerative medicine and wound care, with several projects in development. Guided by Gorman's expertise and experience, the company combines scientific integrity, practical application, and patient-centered design, helping shape the future of advanced wound management while delivering meaningful support to those who need it most.

"It's wonderful to be in the business of helping people," he adds. "We're not only helping patients by providing them a solution to manage wounds; we're doing it with something that already exists in them. That's the level of innovation we foster at Maiden Biosciences."